SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-175601
Filing Date
2022-06-16
Accepted
2022-06-16 17:03:02
Documents
19
Period of Report
2022-06-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d357403d8ka.htm   iXBRL 8-K/A 32460
2 EX-1.1 d357403dex11.htm EX-1.1 169593
3 EX-4.1 d357403dex41.htm EX-4.1 65444
4 EX-5.1 d357403dex51.htm EX-5.1 6948
5 EX-99.1 d357403dex991.htm EX-99.1 9740
9 GRAPHIC g357403dsp045.jpg GRAPHIC 3229
10 GRAPHIC g357403g0617013455294.jpg GRAPHIC 4770
11 GRAPHIC g357403g0617013455419.jpg GRAPHIC 5237
  Complete submission text file 0001193125-22-175601.txt   509913

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cogt-20220613.xsd EX-101.SCH 2864
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cogt-20220613_lab.xml EX-101.LAB 19446
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cogt-20220613_pre.xml EX-101.PRE 12147
13 EXTRACTED XBRL INSTANCE DOCUMENT d357403d8ka_htm.xml XML 3927
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38443 | Film No.: 221021350
SIC: 2834 Pharmaceutical Preparations